• Alligator Bioscience will hold an extraordinary general meeting on November 27, 2026, at Medicon Village in Lund, Sweden.
• Shareholders will vote on a 1-for-1,000 reverse stock split, reducing ordinary shares to 3,568,107.
• The proposal includes issuing 152 ordinary shares to Vator Securities at SEK 0.005 each, alongside amendments to share-count limits.
• A proposed authorization would allow free warrant issues exclusively to Fenja Capital II to fulfill loan-agreement obligations until the next annual meeting.
• Other business includes board elections, selection of the board chair and decisions on board size and remuneration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alligator Bioscience AB published the original content used to generate this news brief on October 27, 2026, and is solely responsible for the information contained therein.